NocturiaNCT01552395
A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
An observational study of Nocturia, run by Ferring Pharmaceuticals at 68 sites in Czechia.
Trial summary
A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Nocturia
- How many people
- 4,136 participants
- Where
- 68 sitesCzechia
- Study dates
- Mar 2012to Apr 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult Patients Suffering From Nocturia 1x or More Times a Night
Who may be able to join
- nocturia
Who cannot join
- habitual or psychogenic polydipsia,
- known or suspected cardiac insufficiency
- other conditions requiring treatment with diuretics
- moderate and severe renal insufficiency
- known hyponatremia
- syndrome of inappropriate ADH secretion
Trial locations and contacts
68 sites in 1 country.
68 sites in 1 country
Czechia68 sites
Nemocnice Rudolfa a Stefanie (there may be other sites in this country)
Benešov
Soukromá ambulance, Benešov
Benešov
Soukromá ambulance Beroun
Beroun
Slezská urologie
Bohunín
URIONTEGRITAS soukromá ambulance
Brno
Uro - clinic
Brno
Urocentrum Brno
Brno
Úrazová nemocnice Brno
Brno
Soukromá ambalance
Citonice
Domažlická Nemocnice
Domažlice
Městská nemocnice Dvůr Králové nad Labem a.s.
Dvůr Králové nad Labem
Nemocnice s poliklinkou Havířov
Havířov
Nemocnice Havlíčkův Brod
Havlíčkův Brod
Gynekologická ambulance Hluk
Hluk
Fakultní nemocnice Hradec Králové
Hradec Králové
PPCHC Sanus Hradec Králové
Hradec Králové
Městská nemocnice Hustopeče
Hustopeče U Brna
Urologická ambulance UROLA
Jaroměř
Soukromá ambulance, Jilemnice
Jilemnice
Oblastní nemocnice Kladno a.s.
Kladno
Urologie s.r.o.
Klatovy
Soukromá ambulance Krnov
Krnov
Kromerizska nemocnice a.s.
Kroměříž
Soukromá ambulance, Lanškroun
Lanškroun
Soukromá ambulance Mohelnice
Mohelnice
Oblastní nemocnice Náchod
Náchod
Sourkomá ambulance, Nový Jičín
Nový Jičín
Nemocnice Nový Jičín
Nový Jíčín
Centrum MEDIOL s.r.o.
Olomouc
FN Olomouc
Olomouc
Městská nemocnice Ostrava
Ostrava
Gynekologická ambulance
Ostrava Ploskovice
Vítkovická Nemocnice a.s.
Ostrava-Vítkovice
Nemocnice Pelhřimov
Pelhřimov
FN Plzeň
Pilsen
Poliklinika Denisovo nábřeží
Pilsen
Nemocnice Písek
Písek
Urologická ambulance
Prachatice
FN Bulovka
Prague
Medicon
Prague
Nemocnice s poliklinikou Praha Italská
Prague
Soukromá ambulance Praha 7
Prague
Soukromá ambulance, Praha 5
Prague
Urocare
Prague
Urologická klinika Praha 1
Prague
Urologické oddělení
Prague
Urologie Zahradní Město s.r.o.
Prague
Urosanté s.r.o
Prague
VFN
Prague
Ústřední vojenská nemocnice
Prague
Urologie - NZZ Lékařský dům
Praha 10 - Uhříněves
JR Urocentrum Přerov s.r.o.
Přerov
Soukromá ambulance, Přeštice
Přeštice
Urocare s.r.o.
Říčany
Soukromá ambulance Štemberk
Štemberk
Nemocnice Tábor
Tábor
Krajská zdravotní - nemocnice Teplice
Teplice
Nemocnice Třebíč
Třebíč
Nemocnice Podlesí a.s.
Třinec
Urologická ambulance
Trutnov
Městská nemocnice Turnov
Turnov
Nemocnice Uherské Hradiště
Uherské Hradiště
Masarykova nemocnice v Ústí nad Labem
Ústí nad Labem
Nemocnice Valašské Meziříčí
Valašské Meziříčí
DUAM s.r.o. Lékařský dům
Zlín
Krajská nemocnice T.Bati a.s.
Zlín
Soukromá ambulance, Zlín
Zlín
UROKAN s.r.o.
Znojmo
About this study
Official title: A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic
A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice
- Conditions
- Nocturia
- Medical subject headings
- Nocturia
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of patients with adverse events
Measured: 24 months
Secondary outcomes (1)
Number of changes in dosage regime
Measured: 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Mar 2012 (estimated)
- Study startMar 2012
- Primary completionApr 2016
- Study completionApr 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for NocturiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Prospective
- Enrolment
- 4,136 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ferring Pharmaceuticals
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Clinical Development Support, Study director, Ferring Pharmaceuticals
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01552395
- Sponsor's protocol ID
- 000056
- Status last verified
- May 2016
- First submitted
- 7 Mar 2012
- Last updated
- 24 May 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 May 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic
- ClinicalTrials.gov ID
- NCT01552395
- Acronym / sponsor ID
- 000056
- Conditions
- Nocturia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,136 participants (actual)
- Lead sponsor
- Ferring PharmaceuticalsIndustry (pharma, biotech, devices)
- Study start
- Mar 2012
- Primary completion
- Apr 2016 (actual)
- Study completion
- Apr 2016 (actual)
- First posted
- 13 Mar 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice
Study design
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult Patients Suffering From Nocturia 1x or More Times a Night
Key inclusion criteria (1 listed)
- nocturia
Key exclusion criteria (6 listed)
- habitual or psychogenic polydipsia,
- known or suspected cardiac insufficiency
- other conditions requiring treatment with diuretics
- moderate and severe renal insufficiency
- known hyponatremia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of patients with adverse events
Time frame: 24 months
1 secondary outcome
Number of changes in dosage regime
Time frame: 24 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 May 2016.
Related trials for Nocturia
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Recruiting
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness
Nocturia, Insomnia
Recruiting
UCon Treatment of Overactive Bladder (OAB) in Males
Urinary Incontinence, Urge Incontinence
Active, not recruiting
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
Active, not recruitingPhase 1/2
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
Survivorship, Prostate Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Clinical Development Support study director
Ferring Pharmaceuticals
68 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Nocturia, run by Ferring Pharmaceuticals at 68 sites in Czechia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 May 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 68 sites in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of patients with adverse events (time frame: 24 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2016.